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Pancreatic cancer (PaCa) is a major health concern due to its aggressiveness and early metastasis. Current treatments for PaCa are
limited by development of resistance against therapy. As an alternative strategy, we assessed the combinatorial eﬀect of dietary
compounds, garcinol and curcumin, on human PaCa cells (BxPC-3 and Panc-1). A signiﬁcant (P<0.05) dose-dependent
reduction in cell viability and increase in apoptosis were observed in both cell lines as compared to untreated controls. A
combination index (CI) value<1, for a two-way comparison of curcumin and garcinol, suggests synergism. The potency (Dm)o f
the combination of garcinol and curcumin was 2 to 10 fold that of the individual agents. This indicates that curcumin and garcinol
in combination exhibit a high level of synergism, with enhanced bioactivity, thereby reducing the required eﬀective dose required
for each individually. This combinatorial strategy may hold promise in future development of therapies against PaCa.
1.Introduction
Cancer is a major health concern across the globe today with
pancreatic cancer (PaCa) being the ﬁfth major cause of
deaths due to cancer in the United States. Development and
progression of this chronic disease involves deregulation and
activation of multiple signaling pathways at diﬀerent stages
of carcinogenesis. This complexity associated with the dis-
ease causes limitations in designing high-eﬃcacy therapeutic
strategies. Although immense work has been done in the
prevention and treatment of PaCa, the results are not satis-
factory and need improvement. For example, gemcitabine is
a standard cytotoxic chemotherapeutic agent used for treat-
ment in PaCa. However, this drug provides limited survival
advantage along with several side eﬀects and development of
chemoresistance [1, 2]. Therefore, exploring new approaches
for better maintenance of this disease is of great interest.
Epidemiological studies have consistently shown that
consumption of a healthy diet including fruits, vegetables,
and whole grains is strongly associated with reduced risk of
cancer and other diseases [3]. Over the years, several natural
bioactive compounds or phytochemicals have been isolated,
identiﬁed, and their potential anticarcinogenic properties
have been evaluated. However, eﬃcacy of interactions
amongst various dietary components needs further analysis.
There is a growing body of evidence that chemotherapeutic
combination strategies would be more eﬃcient in reducing
drugtoxicity,inhibitingtumordevelopmentandprogression
thanwitheitheragentalone.Researchsuggeststhatincreased
consumption of curcumin isolated from Curcuma longa or
Turmeric, contributes to lower risk of cancer in Asian (In-
dian) populations as compared to industrialized western
nations [4, 5]. Also recently, the anticancer properties of
garcinol, a bioactive compound derived from the rind of
the fruit, Garcinia indica, Kokum or Mangosteen has been
revealed. The anticarcinogenic properties of this compound
in several cancers such as breast, oral, and colon cancer have
been tested. Very recently, we and others have showed that
garcinol reduces pancreatic cancer cell viability and increases
apoptosis via downregulation of nuclear factor NF-κB[ 6, 7].
Asian (Indian) populations consume turmeric and kokum as
a spice in their diet regularly. It is possible that the lower
incidence of pancreatic cancer in India (according to 2008
statistics, 2 cases per 100,000 persons per year) as compared2 Journal of Oncology
to the western nations (in 2008, an estimated 37,680 new
cases of pancreatic cancer (18,770 in men and 18,910 in
women) were diagnosed in the United States) [3, 8]m i gh tb e
attributed in part from interactions between the bioactive
components in diet including that of turmeric and kokum.
When a combination of two or more compounds exhibit
a more potent therapeutic eﬀect than that of individual com-
pounds at equal concentrations, the eﬀect is described to be
a synergistic one. In this study, we tested the hypothesis that
the bioactive compounds garcinol from Garcinia indica and
curcumin derived from Curcuma longa will work in syner-
gism and inhibit the growth of PaCa cells. Therefore, gar-
cinol, curcumin, and their combination were tested in PaCa
celllines BxPC-3 and Panc-1, carrying wildtype and mutated
K-ras, respectively. Our results indicate that the combination
of garcinol and curcumin signiﬁcantly inhibited cell viability
(P<0.05) and caused induction of apoptosis via upregula-
tion of caspase-3 and -9 activity (P<0.05) in both cell lines.
The combination proved to be synergistic and/or additive.
These data suggest a potential for the combination therapy
for improvement of eﬃcacy in PaCa treatment and hence
warrants further investigation.
2.MaterialandMethods
2.1. Cell Culture. Human pancreatic carcinoma cell lines
BxPC-3 and Panc-1 were obtained from American Type
Culture Collection (Manassas, VA, USA). The cell lines were
maintained in continuous exponential growth by twice a
week passage in RPMI-1640 medium (Cellgro Manassas,
VA; BxPC-3 cells) and Dulbecco modiﬁed Eagle’s medium
(DMEM, Cellgro Manassas, VA; Panc-1 cells), respectively
and supplemented with 10% fetal bovine serum, 100
units/mLpenicillin,and10mg/mLstreptomycininahumid-
iﬁed incubator containing 5% CO2 in air at 37◦C. Each cell
line was split regularly before attaining 70–80% conﬂuence.
2.2.Reagents. Garcinol(≥95%(TLC),BiomolInternational,
USA) and curcumin (≥94% (curcuminoid content), ≥80%
(Curcumin) Sigma Aldrich, USA) were dissolved in DMSO
to make 20mM stock solution.
2.3. Cell Viability. Cells were seeded at a density of 3 × 103
cells/well in 96-well microtiter culture plates. After overnight
incubation, the medium was removed and replaced with
fresh medium containing diﬀerent concentrations of garci-
nol (0–40μM) diluted from a 20mM stock and/or curcumin
(0–50μM). After 72hrs, MTS (3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt) solution was added to each well and
incubated further for one hour. Color development was
measuredspectrophotometricallyat595nmonaplatereader
(BIO-TEK Instruments) and quantiﬁed as per the
manufacturer’s protocol (Promega, USA). Cell viability has
been expressed as a percentage, for each treatment group
relative to control in the absence of garcinol or curcumin.
2.4. Quantiﬁcation of Apoptosis. T h ec e l la p o p t o s i sE L I S A
Detection Kit (Roche, Palo Alto, CA, USA) was used to
detect apoptosis according to the manufacturer’s protocol.
Brieﬂy, after treatment of BxPC-3 and Panc-1 cells with gar-
cinol or curcumin for 48hrs, the cytoplasmic histone/DNA
fragments from cells were extracted and bound to immo-
bilized antihistone antibody. Subsequently, a peroxidase-
conjugated anti-DNA antibody was used for the detection of
immobilized histone/DNA fragments. After addition of the
peroxidase substrate, the absorbance by the samples was
determined at 405nm with an ULTRA Multifunctional
Microplate Reader (BIO-TEK Instruments).
2.5. Morphological Changes. Morphological changes char-
acteristic of apoptosis were determined by DAPI (4 ,6 -
diamidino-2-phenylindole) staining as per manufacturer’s
protocol (Invitrogen, USA). Brieﬂy, 5×103 cells were seeded
into 6-well plates containing 1-2mL medium. After 24–
36hrs, garcinol and/or curcumin was added and incubated
for another 48hrs. Cells were harvested by trypsinization,
washedwithPBS,andsubsequentlyincubatedfor30minutes
withDAPIatroomtemperatureindarkfor30minutes.Prior
to microscopic analysis, the cells were stained with Prolong
Gold Antifade reagent and visualized under Fluorescence
Microscope (Nikon Eclipse, 80i) with an excitation maxi-
mum at 358nm and an emission maximum at 461nm.
2.6. Caspase Activity. Caspase-3 and -9 activities were mea-
sured in whole-cell lysates prepared from garcinol and/or
curcumin-treated samples using a commercially available
assay kit (R&D Assay System, Minneapolis, MN, USA)
according to the manufacturer’s instructions.
2.7. Analysis of Cytotoxic Synergy. Cells were plated as
described above and allowed to attach overnight. The cul-
ture medium was replaced with fresh medium containing
curcumin and garcinol individually or in combination in
diﬀerent ratios of 1:2.5, 1:5, and 1:10 for 72hrs, and the
eﬀectoncellgrowthwasexamined by theMTSassaymethod
as described above and then analyzed using the Calcusyn
(Biosoft) software program, which utilizes the T.C. Chou
method of determining synergy and antagonism.
The combination index was determined at a 25%, 50%,
and75%toxicitylevelforeachcelllineandateachdrugratio.
The median-eﬀect equation and combination index (CI)
analysis was used to calculate the interaction between treat-
ment modalities. This analysis determines if the eﬀect of the
combination is antagonistic, additive, or synergistic. A CI
valueofoneindicatesthattheeﬀectofonedrugisadditiveto
the second, a CI value of greater than one indicates antag-
onism between the two agents, and a CI value of less than
one indicates synergism between the agents. The equation
used to calculate CI is as follows: (D)1/(Dx)1+(D)2/(Dx)2+
α(D)1(D)2/(Dx)1(Dx)2, where (Dx)1 and (Dx)2 are the
doses for x% inhibition by drug 1 and drug 2 alone [9].
These values are obtained from the median-eﬀect equation.
(D)1 and (D)2 are the doses in combination that inhibit cell
growth by x%. A more detailed description of degrees of
synergism and antagonism is adapted from Chou and Hay-
ball (CalcuSyn, Windows software for dose eﬀect analysis.
Cambridge: Biosoft, 1996).Journal of Oncology 3
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Figure 1: Percentage of metabolically viable cells was reduced in a dose-responsive manner on 48hr treatment with garcinol (upper panel)
or curcumin (lower panel) in both PaCa cell lines. (a) BxPC-3 and (b) Panc-1 as analyzed using MTS assay. ∗P<0.05 relative to control.
3. Results andDiscussion
3.1. Cell Viability. BxPC-3 and Panc-1 cells were tested for
their eﬀects on cell viability under the inﬂuence of curcumin
or garcinol. Both cell lines are p53 mutated with diﬀerences
in their K-ras mutation status. Panc-1 is a poorly diﬀeren-
tiated PaCa cell line with a mutated K-ras, whereas BxPC-3
is a moderately diﬀerentiated PaCa cell line with a wild type
K-ras. We observed that both curcumin and garcinol signiﬁ-
cantly (P<0.05) reduced cell viability in both cell lines in a
dose-dependentmanner.However,garcinolexhibitedamore
potent eﬀect (IC50 = ∼7μM) in Panc-1 cells which was
comparable to the eﬃcacy of curcumin (IC50 = ∼10μM) in
BxPC-3cellsasseeninFigure1.Cellswithmutantoncogenes
such as K-ras continue to grow even when they are not
receiving any growth signals. Both the agents reduced cell
viability but to varying extents.
Garcinol and curcumin hold structural resemblance, but
our results suggest that their therapeutic mechanistic targets
might be diﬀerent. Overall, this indicates that garcinol might
play an important role in targeting the K-ras pathway. In
BxPC-3 cells (Figure 1(a)) IC50 for garcinol treatment
(upper panel) was observed at approximately 15μMa sc o m -
pared to 10μM curcumin treatment for 48 hours. In addi-
tion, in Panc-1 cells (Figure 1(b)) IC50 values for garcinol
(upper panel) and curcumin treatment were 7μMa n d
25μM,respectively.Weandothershaveconsistentlyreported
no toxicity at treatment dose of either curcumin [10]o r
garcinol [6, 7] on normal cells. Hence, these two agents in
combination could be a useful strategy for the treatment of
this aggressive disease.
3.2. Apoptotic Induction. In order to conﬁrm whether the
reduction in cell viability was in part due to apoptotic induc-
tion, we performed the ELISA assays and saw that both gar-
cinol (upper panel) and curcumin (lower panel) induced
apoptosis in a dose-dependent manner in both PaCa cell
lines, BxPC-3 (Figure 2(a)) and Panc-1 (Figure 2(b)). Nor-
mal cells become malignant when cellular tumor suppressor
genes are rendered nonfunctional through mutations. Both
Panc-1 and BxPC-3 exhibit a p53 mutation. p53 is a key
tumor suppressor protein that limits cell proliferation by
inducingcellcyclearrestandapoptosisinresponsetocellular
stress. Hence, the role of p53-independent pathways such as
retinoblastoma protein (Rb) or p73α in induction of apop-
tosis needs further investigation. We determined morpho-
logical changes associated with apoptosis, such as formation
of apoptotic bodies and reduction in cell number using the
DAPI stain as in Figures 2(c) and 2(d) in both PaCa cell lines
upon treatment.4 Journal of Oncology
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Figure 2: Garcinol-(upper panel) or curcumin-(lower panel) treated cytosolic extracts were used to evaluate induction of apoptosis in PaCa
cells. (a) BxPC-3 and (b) Panc-1 using ELISA-Histone DNA Enrichment Assay. Results demonstrate a signiﬁcant dose-dependent increase
in apoptotic cells in individual treatment with either agent for 48 hours. Enrichment factor was measured using subtraction of background
signal. ∗P<0.05 relative to control. Apoptotic morphological changes such as abnormal nuclear morphology, reduction in cell number with
apoptotic body formation, and cell shrinkage were observed in a dose responsive manner on 48 hour treatment with (c) curcumin or (d)
garcinol. BxPC-3 and Panc-1 cells were ﬁxed with DAPI stain and visualized using ﬂuorescence microscopy with an excitation maximum at
358nm and emission maximum at 461nm.Journal of Oncology 5
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Figure3:Apoptoticmorphologicalchangessuchasabnormalnuclearmorphology,reductionincellnumberwithapoptoticbodyformation,
and cell shrinkage induced by combination treatment with curcumin and garcinol in diﬀerent ratios for 48 hours were observed using DAPI
staininbothPaCacelllines:BxPC-3(leftpanel)andPanc-1(rightpanel).(1:4ratiois2.5μM:10μMconcentrationand1:10ratiois2μM:
20μM respective concentrations).
Both BxPC-3 (Figure 3 left panel) and Panc-1 (Figure 3
right panel) were subjected to diﬀerent concentrations of
curcumin and garcinol individually, and reduction in cell
number along with formation of apoptotic bodies was
observed as a dose-dependent eﬀect. Figure 3 depicts the
s t r u c t u r a lc h a n g e sw h e nc u r c u m i na n dg a r c i n o lw e r eg i v e n
in combination in diﬀerent ratios (1:4 ratio is 2.5μM:
10μM concentration and 1:10 ratio is 2μM:20μMr e s p e c -
tive concentrations). Combination treatment had a more
pronounced eﬀect on induction of apoptosis than their
respective individual treatments.
3.3. Caspase Activity. Caspases are a family of cysteine pro-
teases that play a very important role in apoptosis. Caspase-9
is an initiator caspase that causes the cleavage of procaspase
to active form, and Caspase-3 is an executioner caspase that
cleaves other protein substrates triggering the process of
apoptosis. We measured caspase-3 and 9 activities using6 Journal of Oncology
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Figure 4: Garcinol and curcumin signiﬁcantly increased Caspase-3 (a and b) and Caspase-9 (c and d) activity by ∼2 to 3 folds in both PaCa
cell lines: BxPC-3 (left panel) and Panc-1 (right panel) relative to untreated control after 48 hour treatment. Caspase activity was measured
in garcinol- and/or curcumin-treated whole cell extracts using colorimetric assay. ∗P<0.05 relative to control.
a colorimetric assay and observed a signiﬁcant 2 to 3 fold
induction of active caspase-3 (P<0.05) (Figures 4(a) and
4(b))a n dc a s p a s e - 9( P<0.05) (Figures 4(c) and 4(d))i n
both Panc-1 and BxPC-3 cells upon treatment with garcinol
and curcumin. Similar or higher induction was observed in
combination treatment with lower doses in diﬀerent ratios.
Caspases are usually associated with the activity of tumor
suppressor genes such as p53, p73α, or Rb. Since both the
cell lines exhibit p53 mutation, activation of caspases-3 and
-9 might be due to the involvement of another tumor sup-
pressor gene, which needs to be conﬁrmed by further anal-
ysis.
3.4. Cytotoxic Synergy. In order to determine the extent of
synergism between these two agents, we tested the combina-
tion eﬀect of garcinol and curcumin in diﬀerent ratios. Cell
viability reduced signiﬁcantly (P<0.05) upon treatment in
Panc-1 cells, and the eﬀects were more pronounced in the
combinatorial approach as compared to individual doses
(Figure 5(a)). Using the Isobologram analysis method, we
determined the combination index values (CI) for diﬀerent
ratios of treatment in Panc-1 cells.
Figure 5(b) shows the diﬀerent CI values obtained upon
treatment. CI = 1 indicates additive eﬀect, <1 indicates syn-
ergistic eﬀect, and >1 suggests antagonistic eﬀect. The CI
values for ED50 (eﬀective dose for 50% inhibition) when
curcumin and garcinol were administered in the ratios of
1:10, 1:5, and 1:2.5 were 0.201, 0.422, and 0.659, respec-
tively. Three combinations were tested for each ratio. Dm
can be deﬁned as the median-eﬀect dose or concentration
signifying the potency of the treatment. It is usually depicted
in correlation with ED50 values. We observed that when
Panc-1 cells were treated with only curcumin and garcinol,
the Dm values were 26μM and 17.65μM, respectively.
However, when curcumin and garcinol were administered
in the ratios of 1:10, 1:5 and 1:2.5, the Dm values were
4.57, 8.57, and 10.79μM, respectively. Based on the CI ED50
values and the Dm values, it can be concluded that there was
2 to 5 fold lower concentration requirement in combination
treatment than individual treatments in order to show
similar eﬀect.
Similarly when the ratio of garcinol and curcumin was
reversed,andthecellsweretreatedwith1:10,1:5,and1:2.5
of garcinol:curcumin, the CI values at ED50 were 0.756,
0.747, and 0.921, respectively. The Dm values recorded forJournal of Oncology 7
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Figure 5:(a)combinationeﬀectofcurcuminandgarcinolonPanc-
1 cell viability was determined using MTS assay. Combinatorial
treatment signiﬁcantly reduced cell viability more eﬀectively than
monotherapy on 48hr treatment. ∗P<0.05 relative to control.
(b) isobologram analysis to evaluate the extent of synergism on
combining curcumin and garcinol for therapeutic eﬀect. Combi-
nation Index (CI) values at ED50 (eﬀective dose at which 50%
cells are nonviable) depicting the synergistic eﬃcacy of garcinol and
curcumin on PaCa cell line.
the same ratios were 1.25, 2.32, and 5.11μM, respectively.
Dm is an important parameter which helps in establishing
dose reduction leading to lowered toxicity in the host, thus
retaining overall therapeutic eﬃcacy.
Another parameter describing the sigmoidicity of the
dose eﬀect curve is the m value. An m = 1, >1, and <1
correlates with a hyperbolic, sigmoidal, and negative sig-
moidal shape, respectively. We observed m>1 value in all
our samples except when curcumin:garcinol were in the
ratio of 1:10 suggesting sigmoidicity of the curve. Also, r
value is the linear correlation coeﬃcient of the median eﬀect
plot. An r value equal or close to 1 indicates perfect con-
formity of the data. We report an r value close to 1 (0.97–
1.00) in all our samples.
Collectively, the above results suggest that dietary inter-
actions can be a beneﬁcial option for the control of PaCa.
This disease is a major health problem because of its increas-
ing incidence worldwide. Given the limited therapeutic
options and current unmatched clinical needs for the treat-
ment of the patient, there is an urgent need for the devel-
opment of novel agents that can inﬂuence the survival rates
and quality of life for the patients. Relatively few studies have
reported that the additive and synergistic eﬀects of phyto-
chemicals in fruits and vegetables are responsible for their
potentanticanceractivities.Oneschoolofthoughtisthatthis
synergistic or additive eﬀect of various bioactive compounds
could be due to targeting of multiple signaling pathways.
Our data clearly exhibited that garcinol in combination with
curcumin had potent synergistic eﬀect on cell viability and
apoptosis.
Dietary modiﬁcation is a practical approach where we
can combine nontoxic phytochemicals from fruits and veg-
etables, and this approach may also enhance the chemother-
apeutic eﬃcacy of malignant cells with minimal toxicity to
normal cells. This study demonstrates a synergistic eﬀect
between curcumin and garcinol in pancreatic cancer cells.
Our ﬁndings have important implications for combination
of diﬀerent dietary agents for cancer therapy. However, fur-
ther studies are needed to elucidate the underlying mech-
anisms of combinatorial approach in pancreatic cancer for
enhancing eﬃcacy and simultaneously lowering cytotoxicity
to normal cells.
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